← Volver a resultados
Ficha bibliográfica · Consulta y acceso
Artículo

In vitro evaluation of commercially available theophylline sustained release tablets in Pakistan

Ranjha, Nazar M. et al · SEDICI UNLP · 2010

Material complementario disponible
Lectura rápida. Revisá los datos básicos del recurso y luego accedé al contenido desde el botón principal. En esta ficha solo se muestra la información necesaria para identificar la obra, citarla y abrirla.

Acceso al recurso

Entrá al contenido desde la opción principal o elegí otra fuente disponible.

Acceso principal

Material complementario disponible

El enlace apunta a material asociado, anexos, tablas, datos o página complementaria. No se marca como libro/texto completo.
Abrir material

Resumen

Descripción general del contenido del recurso.

The dissolution behavior of five commercially available brands of sustained release theophylline
tablets was studied in phosphate buffer solutions of pH 1.2, 4.5, 5.5, 6.0 and 7.5 at 37 °C using the
USP dissolution apparatus II (paddle method). Drug concentration in the samples was determined spectrophotometrically
at 272 nm. For predicting the release characteristics of theophylline from selected commercially
available tablets the data obtained in the dissolution studies was fitted into various mathematic
models defining kinetic parameters of drug release like zero-order rate equation, first-order rate equation,
Hixen-crowell cube root law, Higuchi equation and Korsemeyer-Peppas model. Tablets were subjected to
weight variation test, hardness, drug content and in vitro release studies. The present study revealed that
drug release increases with the increase of pH of the dissolution medium and also varies from brand to
brand. Among the five selected brands, B1 and B4 showed better pH dependency and drug release behaviour.
It has been suggested that possible reasons for difference in dissolution or drug release behaviour
are the difference in the manufacturing techniques and the quantity of hydrophobic excepients used by
different manufacturers, which retard the penetration of dissolution medium and ultimately decreases
availability of drug in the solution.
Colegio de Farmacéuticos de la Provincia de Buenos Aires

Cómo citar

Elegí el formato que necesitás y copiá la referencia al portapapeles.

APA 7

Ranjha, N. M. E. A. (2010). In vitro evaluation of commercially available theophylline sustained release tablets in Pakistan. http://sedici.unlp.edu.ar/handle/10915/7998

MLA

Ranjha, Nazar M. et al. "In vitro evaluation of commercially available theophylline sustained release tablets in Pakistan." 2010. http://sedici.unlp.edu.ar/handle/10915/7998.

Chicago

Ranjha, Nazar M. et al. 2010. "In vitro evaluation of commercially available theophylline sustained release tablets in Pakistan.". http://sedici.unlp.edu.ar/handle/10915/7998.

Harvard

Ranjha, N. M. E. A. 2010, In vitro evaluation of commercially available theophylline sustained release tablets in Pakistan, SEDICI UNLP, available at: http://sedici.unlp.edu.ar/handle/10915/7998 [Accessed 25 Jun. 2026].

Compartir e imprimir

Guardá la ficha, copiá su enlace permanente o imprimila como PDF.

Exportar referencia

Si usás un gestor bibliográfico, podés exportar el registro en los formatos más comunes.

Detalles del recurso

Información bibliográfica útil para confirmar que se trata del material correcto.

Título
In vitro evaluation of commercially available theophylline sustained release tablets in Pakistan
Autor / colaboradores
Ranjha, Nazar M. et al
Editorial
SEDICI UNLP
Año de publicación
2010
Idioma
en

Materias

Explorá otros recursos relacionados a partir de estas materias.

Copiado